deltatrials
Active Not Recruiting OBSERVATIONAL NCT03064087

Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples (VALHUDES)

Validation of Human Papillomavirus Assays and Collection Devices for HPV Testing on Self-samples and First-void Urine Samples (VALHUDES)

Sponsor: Algemeen Medisch Laboratorium

Conditions Cervical Intraepithelial Neoplasia Grade 2/3
Interventions Abbott RealTime High Risk HPV Colli-Pee Evalyn Brush Multi-Collect Swab Qvintip
Updated 16 times since 2017 Last updated: Mar 28, 2023 Started: Dec 29, 2017 Primary completion: Dec 31, 2024 Completion: Nov 17, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cervical Intraepithelial Neoplasia Grade 2/3, this trial is ongoing. The trial is conducted by Algemeen Medisch Laboratorium and has accumulated 16 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2017 – ~Aug 2017 · 5 months · monthly snapshot~Aug 2017 – ~Feb 2018 · 6 months · monthly snapshot~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Aug 2019 · 11 months · monthly snapshot~Aug 2019 – ~Feb 2020 · 6 months · monthly snapshot~Feb 2020 – ~Nov 2020 · 9 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Dec 2021 · 6 months · monthly snapshot~Dec 2021 – ~Apr 2023 · 16 months · monthly snapshot~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Active Not Recruiting

  2. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  3. Apr 2023 — Jul 2024 [monthly]

    Active Not Recruiting

  4. Dec 2021 — Apr 2023 [monthly]

    Active Not Recruiting

  5. Jun 2021 — Dec 2021 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

▶ Show 11 earlier versions

  1. Jan 2021 — Jun 2021 [monthly]

    Recruiting

  2. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  3. Feb 2020 — Nov 2020 [monthly]

    Recruiting

  4. Aug 2019 — Feb 2020 [monthly]

    Recruiting

  5. Sep 2018 — Aug 2019 [monthly]

    Recruiting

  6. Jun 2018 — Sep 2018 [monthly]

    Recruiting

  7. May 2018 — Jun 2018 [monthly]

    Recruiting

  8. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  9. Feb 2018 — Apr 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  10. Aug 2017 — Feb 2018 [monthly]

    Not Yet Recruiting NA

  11. Mar 2017 — Aug 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Algemeen Medisch Laboratorium
  • Marc Arbyn
  • Regionaal Ziekenhuis Heilig Hart Tienen
  • Universitair Ziekenhuis Brussel
  • Universiteit Antwerpen
  • University Hospital, Antwerp
  • University Hospital, Ghent
Data source: Sciensano

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations